International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Cardiovascular Diseases in HIV-Infected Patients at Kamenge Teaching Hospital in Burundi

Dionys Nsanzabagenzi, Epipode Ntawuyamara, Pengfei Ye, Hongxin Niu

Department of Nephrology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China; Department of Nephrology, Kamenge Military Hospital, Bujumbura, Burundi; Department of Dermatology and Venereology, Faculty of Medicine, Kamenge Teaching Hospital, University of Burundi, P. Box 1020, Bujumbura, Burundi; Department of Dermatology, Cosmetology, and Venereology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China; Special Medical Service Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China

Article Information

Volume / Issue5 / 4 (October-December 2024)
Pages49-56
AccessOpen Access

Publication Timeline

  • Received11 August 2024
  • Accepted16 September 2024

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Introduction: HIV-positive individuals are more prone to developing cardiovascular disease because of HIV-specific and non-traditional risk factors. This study aimed to describe cardiovascular diseases associated with HIV/AIDS in low-income settings.

Materials and methods: The study conducted at Kamenge Teaching Hospital in Burundi, from January 2022 to December 2023 was a prospective, observational study aimed at providing clinical and descriptive insights into HIV-infected patients receiving ARV medication, focusing on cardiovascular disease, positive HIV serology, and no prior cardiovascular disease.

Results: This study included 38 participants with cardiovascular disease from 115 HIV-infected patients (33.04 %). Our study included 26 (68.42%) women and 12 (31.58%) men. Their mean age was 48.60 ± 11.58 years. Widowhood was associated with cardiovascular disease in HIV-infected patients in our study, as indicated by the statistical analysis (p = 0.0171, χ2 = 9.6611 for CI = 95%). In our comprehensive study of cardiovascular diseases, deep vein thrombosis (DVT) emerged as the predominant condition, accounting for 34.21% of cases, followed by dilated cardiomyopathy at 28.95%. Valvular heart disease (21.05%), ischemic heart disease (18.42%), hypertension (15.79%), pericarditis (13.16%), and stroke and pulmonary arterial hypertension (7.89%) were also observed. Furthermore, pulmonary embolism and arrhythmia-induced cardiomyopathy were present in 2.63% of the study participants.

Conclusion: Cardiovascular diseases are diverse among patients with HIV infection. The most prevalent complications were deep vein thrombosis of the lower limbs, followed by dilated cardiomyopathy, valvular cardiomyopathy, ischemic cardiomyopathy, and hypertension, which caused heart failure in young people with severe immunosuppression.

Keywords

Cardiovascular Diseasesantiretroviral therapyDeep vein thrombosisDilated cardiomyopathy

References

  1. Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of cardiovascular disease among people living with HIV: A systematic review and meta-analysis. HIV Medicine. 2012;13:453–468. [Google Scholar][Crossref]
  2. Shah ASV, Stelzle D, Ken Lee K, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: A systematic review and meta-analysis. Circulation. 2018;138:1100–1112. [Google Scholar][Crossref]
  3. Smit M, Brinkman K, Geerlings S, et al. Future challenges for clinical care of an ageing population infected with HIV: A modelling study. The Lancet Infectious Diseases. 2015;15:810–818. [Google Scholar][Crossref]
  4. Nash D, Yotebieng M, Sohn AH. Treating all people living with HIV in sub-Saharan Africa: A new era calling for new approaches. 2018. [Google Scholar][Crossref]
  5. Hontelez JAC, De Vlas SJ, Baltussen R, et al. The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa. AIDS. 2012;26. [Google Scholar][Crossref]
  6. Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of cardiovascular disease among people living with HIV: A systematic review and meta-analysis. HIV Medicine. 2012;13:453–468. [Google Scholar][Crossref]
  7. Abelman RA, Mugo BM, Zanni MV. Conceptualizing the risks of coronary heart disease and heart failure among people aging with HIV: Sex -specific considerations. Current Treatment Options in Cardiovascular Medicine; c2019:21. [Google Scholar][Crossref]
  8. Paisible AL, Chang CCH, So-Armah KA, et al. HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction. Journal of Acquired Immune Deficiency Syndromes (1988). 2015;68:209-216. [Google Scholar][Crossref]
  9. Neuhaus J, Jacobs DR, Baker JV, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. The Journal of Infectious Diseases. 2010;201:1788-1795. [Google Scholar][Crossref]
  10. Zhang Q, Peng F, Li M, Yi Q, Tang W, Wu S. Elevated risk of venous thromboembolism in people living with HIV. Viruses; c2022:14. [Google Scholar][Crossref]
  11. O’Brien M, Montenont E, Hu L, et al. Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: A pilot study. Journal of Acquired Immune Deficiency Syndromes (1988). 2013;63:280-288. [Google Scholar][Crossref]
  12. Yan C, Li R, Guo X, et al. Cardiac involvement in human immunodeficiency virus-infected patients: An observational cardiac magnetic resonance study. Frontiers in Cardiovascular Medicine; c2021:8. [Google Scholar][Crossref]
  13. Fabian J, Naicker S. HIV and kidney disease in sub-Saharan Africa. Nature Reviews Nephrology. 2009;5:591-598. [Google Scholar][Crossref]
  14. Bollyky TJ, Templin T, Cohen M, Dieleman JL. Lower-income countries that face the most rapid shift in noncommunicable disease burden are also the least prepared. Health Affairs. 2017;36:1866-1875. [Google Scholar][Crossref]
  15. Marquez PV, Farrington JL. No more disease silos for sub-Saharan Africa. BMJ (Online); c2012:345. [Google Scholar][Crossref]
  16. Freiberg MS, Chang CCH, Kuller LH, et al. HIV infection and the risk of acute myocardial infarction. JAMA Internal Medicine. 2013;173:614-622. [Google Scholar][Crossref]
  17. Paisible AL, Chang CCH, So-Armah KA, et al. HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction. Journal of Acquired Immune Deficiency Syndromes (1988). 2015;68:209-216. [Google Scholar][Crossref]
  18. Durand M, Sheehy O, Baril JG, Lelorier J, Tremblay CL. Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: A International Journal of Medical and All Body Health Research www.allmedicaljournal.com cohort and nested case–control study using Québec’s public health insurance database. JAIDS Journal of Acquired Immune Deficiency Syndromes; c2011:57. [Google Scholar][Crossref]
  19. Stone L, Looby SE, Zanni MV. Cardiovascular disease risk among women living with HIV in North America and Europe. Current Opinion in HIV and AIDS. 2017;12:585-593. [Google Scholar][Crossref]
  20. Toribio M, Awadalla M, Cetlin M, et al. Brief report: Vascular dysfunction and monocyte activation among women with HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes; c2020:85. [Google Scholar][Crossref]
  21. Alonso A, Barnes AE, Guest JL, Shah A, Shao IY, Marconi V. HIV infection and incidence of cardiovascular diseases: An analysis of a large healthcare database. Journal of the American Heart Association. c2019;8. [Google Scholar][Crossref]
  22. Maulsby CH, Ratnayake A, Hesson D, Mugavero MJ, Latkin CA. A scoping review of employment and HIV. AIDS and Behavior. 2020;24:2942-2955. [Google Scholar][Crossref]
  23. D’Arminio Monforte A, Cozzi-Lepri A, Girardi E, et al. Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: Prevalence and clinical outcome. Antiviral Therapy. 2011;16:1103-1112. [Google Scholar][Crossref]
  24. Joy R, Druyts E, Brandson EK, et al. Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2008;47:500-505. [Google Scholar][Crossref]
  25. Wand H, Morris N, Moodley J, Naidoo S, Reddy T. Impact of marital status on risk of HIV in South Africa (2002–2017). AIDS Care. 2023;35:739-744. [Google Scholar][Crossref]
  26. Heikinheimo T, Chimbayo D, Kumwenda JJ, Kampondeni S, Allain TJ. Stroke outcomes in Malawi, a country with high prevalence of HIV: A prospective follow-up study. PLOS ONE; c2012:7. [Google Scholar][Crossref]
  27. Benjamin LA, Corbett EL, Connor MD, et al. HIV, antiretroviral treatment, hypertension, and stroke in Malawian adults: A case-control study; c2015. [Google Scholar][Crossref]
  28. Arentzen M, Jubt F, Evers S, et al. Cerebrovascular events in HIV-infected patients: An analysis of a cohort of 3203 HIV+ patients during the times of cART. International Journal of Neuroscience. 2015;125:601– 611. [Google Scholar][Crossref]
  29. Wearne N, Swanepoel CR, Boulle A, Duffield MS, Rayner BL. The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators, and clinical correlations. Nephrology Dialysis Transplantation. 2012;27:4109–4118. [Google Scholar][Crossref]
  30. Biondi-Zoccai G, D’Ascenzo F, Modena MG. Novel insights on HIV/AIDS and cardiac disease: Shedding light on the HAART of darkness. European Heart Journal. 2012;33:813–815. Copyright and License © The Author(s). Authors retain the copyright of their published articles. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution Non Commercial-Share A like 4.0 International (CC BY-NC-SA 4.0) License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. [Google Scholar][Crossref]

How to Cite

Nsanzabagenzi, D., Ntawuyamara, E., Ye, P., & Niu, H. (2024). Cardiovascular Diseases in HIV-Infected Patients at Kamenge Teaching Hospital in Burundi. International Journal of Medical and All Body Health Research, 5(4), 49-56. https://doi.org/10.54660/IJMBHR.2024.5.4.49-56

Nsanzabagenzi, Dionys, et al. "Cardiovascular Diseases in HIV-Infected Patients at Kamenge Teaching Hospital in Burundi." International Journal of Medical and All Body Health Research, vol. 5, no. 4, 2024, pp. 49-56. https://doi.org/10.54660/IJMBHR.2024.5.4.49-56.

Nsanzabagenzi, D., Ntawuyamara, E., Ye, P. and Niu, H. (2024) 'Cardiovascular Diseases in HIV-Infected Patients at Kamenge Teaching Hospital in Burundi', International Journal of Medical and All Body Health Research, 5(4), pp. 49-56. doi: 10.54660/IJMBHR.2024.5.4.49-56.

Nsanzabagenzi D, Ntawuyamara E, Ye P, Niu H. Cardiovascular Diseases in HIV-Infected Patients at Kamenge Teaching Hospital in Burundi. International Journal of Medical and All Body Health Research. 2024;5(4):49-56. doi:10.54660/IJMBHR.2024.5.4.49-56

Similar Articles

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.